Abhishek Kumar Singh
Yale University
H-index: 22
North America-United States
Top articles of Abhishek Kumar Singh
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Dynamic metabolism of endothelial triglycerides protects against atherosclerosis in mice | The Journal of Clinical Investigation | Nabil E Boutagy Ana Gamez-Mendez Joseph WM Fowler Hanming Zhang Bal K Chaube | 2024/2/15 |
Suppression of angiopoietin-like 4 reprograms endothelial cell metabolism and inhibits angiogenesis | Nature Communications | Balkrishna Chaube Kathryn M Citrin Mahnaz Sahraei Abhishek K Singh Diego Saenz de Urturi | 2023/12/12 |
Loss of cis-PTase function in the liver promotes a highly penetrant form of fatty liver disease that rapidly transitions to hepatocellular carcinoma | bioRxiv | Abhishek K Singh Balkrishna Chaube Kathryn M Citrin Joseph Wayne Fowler Sungwoon Lee | 2023/11/15 |
Genetic or therapeutic neutralization of ALK1 reduces LDL transcytosis and atherosclerosis in mice | Nature cardiovascular research | Sungwoon Lee Hubertus Schleer Hyojin Park Erika Jang Michael Boyer | 2023/5 |
Brown adipose TRX2 deficiency activates mtDNA-NLRP3 to impair thermogenesis and protect against diet-induced insulin resistance | The Journal of Clinical Investigation | Yanrui Huang Jenny H Zhou Haifeng Zhang Alberto Canfran-Duque Abhishek K Singh | 2022/5/2 |
Targeting the vasculature in cardiometabolic disease | Nabil E Boutagy Abhishek K Singh William C Sessa | 2022/3/15 | |
Metabolism and Medicine: The Metabolic Landscape of Health and Disease (Volume 2) | Brian Fertig | 2022/1/31 | |
Estradiol overcomes adiponectin-resistance in diabetic mice by regulating skeletal muscle adiponectin receptor 1 expression | Molecular and Cellular Endocrinology | Sourav Chattopadhyay Amit Joharapurkar Nabanita Das Shamima Khatoon Sapana Kushwaha | 2022/1/15 |
Fibronectin–Integrin α5 Signaling in Vascular Complications of Type 1 Diabetes | Diabetes | Minghao Chen Rui Hu Cristina Cavinato Zhenwu W Zhuang Jiasheng Zhang | 2022/9/1 |
Hepatocyte-specific suppression of ANGPTL4 improves obesity-associated diabetes and mitigates atherosclerosis in mice | The Journal of Clinical Investigation | Abhishek K Singh# Balkrishna Chaube# Xinbo Zhang Jonathan Sun Kathryn M Citrin | 2021/7/13 |
Loss of hepatic miR-33 improves metabolic homeostasis and liver function without altering body weight or atherosclerosis | Proceedings of the National Academy of Sciences | Nathan L Price Xinbo Zhang Pablo Fernández-Tussy Abhishek K Singh Sean A Burnap | 2021/2/2 |
Desmosterol suppresses macrophage inflammasome activation and protects against vascular inflammation and atherosclerosis | Proceedings of the National Academy of Sciences | Xinbo Zhang Jeffrey G McDonald Binod Aryal Alberto Canfrán‐Duque Emily L Goldberg | 2021/11/23 |
Leprosy drug clofazimine activates peroxisome proliferator-activated receptor-γ and synergizes with imatinib to inhibit chronic myeloid leukemia cells | Haematologica | Harish Kumar Sourav Chattopadhyay Nabanita Das Sonal Shree Dinesh Patel | 2020/4 |
Combination of clofazimine and imatinib for effective therapy of drug-resistant myeloid leukemia | 2020/3/3 | ||
Disulfiram treatment normalizes body weight in obese mice | Cell metabolism | Michel Bernier Sarah J Mitchell Devin Wahl Antonio Diaz Abhishek Singh | 2020/8/4 |
Elucidating the mechanisms by which disulfiram protects against obesity and metabolic syndrome | npj Aging and Mechanisms of Disease | Michel Bernier Dylan Harney Yen Chin Koay Antonio Diaz Abhishek Singh | 2020/7/21 |
Liver-specific suppression of ANGPTL4 improves obesity-associated diabetes and mitigates atherosclerosis in mice | bioRxiv | Abhishek K Singh Balkrishna Chaube Alberto Canfrán-Duque Xinbo Zhang Nathan L Price | 2020/6/3 |
Co-Authors
